Publications

Saleh, N., Moutereau, S., Durr, A., Krystkowiak, P., Azulay, J., Tranchant, C., Broussolle, E., Morin, F., Bachoud-Levi, A. & Maison, P. (2009). Neuroendocrine disturbances in Huntington's disease. PloS one, 4(3), e4962. doi:10.1371/journal.pone.0004962

Salem, L., Saleh, N., Désaméricq, G., Youssov, K., Dolbeau, G., Cleret de Langavant, L., Bourhis, M., Azulay, J., Krystkowiak, P., Verny, C., Morin, F., Moutereau, S., French Huntington Study, G., Bachoud-Levi, A. & Maison, P. (2016). Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease. PloS one, 11(9), e0162890. doi:10.1371/journal.pone.0162890

Salem, L., Saleh, N., Youssov, K., Olivier, A., Charles, P., Scherer, C., Verny, C., Bachoud-Levi, A. & Maison, P. (2014). The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials. Fundamental & clinical pharmacology, 28(6), 700-10. doi:10.1111/fcp.12077

Sambin, S., Teichmann, M., De Diego Balaguer, R., Giavazzi, M., Sportiche, D., Schlenker, P. & Bachoud-Levi, A. (2012). The role of the striatum in sentence processing: disentangling syntax from working memory in Huntington's disease. Neuropsychologia, 50(11), 2625-35. doi:10.1016/j.neuropsychologia.2012.07.014

Schramm, C., Bachoud-Levi, A. & Katsahian, S. (2018). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Stat Methods Med Res, 27(1), 97-113. doi:10.1177/0962280215621591

Schramm, C., Katsahian, S., Youssov, K., Démonet, J., Krystkowiak, P., Supiot, F., Verny, C., Cleret de Langavant, L. & Bachoud-Levi, A. (2015). How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease. PLoS ONE. doi:10.1371/journal.pone.0145842

Schramm, C., Vial, C., Bachoud-Levi, A. & Katsahian, S. (2015). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Statistical methods in medical research, 27(1), 97-113. doi:10.1177/0962280215621591

Shin, M., Jan, C., Jacquard, C., Jarraya, B., Callebert, J., Launay, J., Hantraye, P., Remy, P., Palfi, S. & Brouillet, E. (2011). Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiology of aging, 32(11), 2100-2. doi:10.1016/j.neurobiolaging.2009.11.015

Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., Scherer, C., Tranchant, C., Goizet, C., Debruxelles, S., Defebvre, L., Sablonnière, B., Romon-Rousseaux, M., Buée, L., Destée, A., Godefroy, O., Durr, A., Landwehrmeyer, B., Registry Study Of The European Huntington'S Disease, N., Bachoud-Levi, A., Richard, F., Blum, D., Krystkowiak, P. & Huntington French Speaking, N. (2013). Association between caffeine intake and age at onset in Huntington's disease. Neurobiology of disease, 58, 179-82. doi:10.1016/j.nbd.2013.05.013

Soulas, T., Cleret de Langavant, L., Monod, V. & Fenelon, G. (2016). The prevalence and characteristics of hallucinations, delusions and minor phenomena in a non-demented population sample aged 60 years and over. . International journal of geriatric psychiatry, 31(12), 1322-1328. doi:10.1002/gps.4437

Squitieri, F., Gellera, C., Cannella, M., Mariotti, C., Cislaghi, G., Rubinsztein, D., Almqvist, E., Turner, D., Bachoud-Levi, A., Simpson, S., Delatycki, M., Maglione, V., Hayden, M. & Donato, S. (2003). Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain : a journal of neurology, 126(Pt 4), 946-55.

Sun, Y., Giavazzi, M., Adda-Decker, M., Barbosa, L., Kouider, S., Bachoud-Levi, A., Jacquemot, C. & Peperkamp, S. (2015). Complex linguistic rules modulate early auditory brain responses. Brain and language, 149, 55-65. doi:10.1016/j.bandl.2015.06.009

Teichmann, M., Gaura, V., Démonet, J., Supiot, F., Delliaux, M., Verny, C., Renou, P., Remy, P. & Bachoud-Levi, A. (2008). Language processing within the striatum: evidence from a PET correlation study in Huntington's disease. Brain : a journal of neurology, 131(Pt 4), 1046-56. doi:10.1093/brain/awn036

Teichmann, M., Rosso, C., Martini, J., Bloch, I., Brugières, P., Duffau, H., Lehericy, S. & Bachoud-Levi, A. (2015). A cortical-subcortical syntax pathway linking Broca's area and the striatum. Human brain mapping, 36(6), 2270-83. doi:10.1002/hbm.22769

Teichmann, M., Darcy, I., Bachoud-Levi, A. & Dupoux, E. (2009). The role of the striatum in phonological processing: evidence from early stages of Huntington's disease. Cortex; a journal devoted to the study of the nervous system and behavior, 45(7), 839-49. doi:10.1016/j.cortex.2008.12.005

Thiriez, C., Itti, E., Fenelon, G., Evangelista, E., Meignan, M., Cesaro, P. & Remy, P. (2015). Clinical routine use of dopamine transporter imaging in 516 consecutive patients. Journal of neurology, 262(4), 909-15. doi:10.1007/s00415-014-7634-y

Thiriez, C., Villafane, G., Grapin, F., Fenelon, G., Remy, P. & Cesaro, P. (2011). Can nicotine be used medicinally in Parkinson's disease? Expert review of clinical pharmacology, 4(4), 429-36. doi:10.1586/ecp.11.27

Thobois, S., Ribeiro, M., Lohmann, E., Durr, A., Pollak, P., Rascol, O., Guillouet, S., Chapoy, E., Costes, N., Agid, Y., Remy, P., Brice, A., Broussolle, E. & French Parkinson'S Disease Genetics Study, G. (2003). Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study. Archives of neurology, 60(5), 713-8. doi:10.1001/archneur.60.5.713

Traykov, L., Raoux, N., Latour, F., Gallo, L., Hanon, O., Baudic, S., Bayle, C., Wenisch, E., Remy, P. & Rigaud, A. (2007). Executive functions deficit in mild cognitive impairment. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 20(4), 219-24. doi:10.1097/WNN.0b013e31815e6254

Trinkler, I., Devignevielle, S., Achaibou, A., Ligneul, R., Brugières, P., Cleret de Langavant, L., De Gelder, B., Scahill, R., Schwartz, S. & Bachoud-Levi, A. (2017). Embodied emotion impairment in Huntington's Disease. Cortex; a journal devoted to the study of the nervous system and behavior, 92, 44-56. doi:10.1016/j.cortex.2017.02.019

Trinkler, I., Cleret de Langavant, L. & Bachoud-Levi, A. (2013). Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings. Cortex; a journal devoted to the study of the nervous system and behavior, 49(2), 549-58. doi:10.1016/j.cortex.2011.12.003

Vaccarino, A., Sills, T., Anderson, K., Bachoud-Levi, A., Borowsky, B., Craufurd, D., Duff, K., Giuliano, J., Groves, M., Guttman, M., Kupchak, P., Ho, A., Paulsen, J., Pedersen, K., Van Duijn, E., Van Kammen, D. & Evans, K. (2011). Assessment of depression, anxiety and apathy in prodromal and early huntington disease. PLoS currents, 3, RRN1242. doi:10.1371/currents.RRN1242

Van Der Gucht, A., Cleret de Langavant, L., Bélissant, O., Rabu, C., Cottereau, A., Evangelista, E., Chalaye, J., Bonnot-Lours, S., Fenelon, G. & Itti, E. (2016). Brain (18)F-FDG, (18)F-Florbetaben PET/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease. Nuclear medicine and molecular imaging, 50(3), 258-60. doi:10.1007/s13139-016-0394-0

Van Der Gucht, A., Aoun Sebaiti, M., Guedj, E., Aouizerate, J., Yara, S., Gherardi, R., Evangelista, E., Chalaye, J., Cottereau, A., Verger, A., Bachoud-Levi, A., Abulizi, M., Itti, E. & Authier, F. (2017). Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 58(3), 492-498. doi:10.2967/jnumed.114.151878

Van Der Gucht, A., Aoun-Sebaiti, M., Kauv, P., Guedj, E., Aouizerate, J., Verger, A., Gherardi, R., Bachoud-Levi, A., Authier, F. & Itti, E. (2016). FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis. Nuclear medicine and molecular imaging, 50(1), 80-4. doi:10.1007/s13139-015-0371-z

Van Der Gucht, A., Aoun Sebaiti, M., Itti, E., Aouizerate, J., Evangelista, E., Chalaye, J., Gherardi, R., Ragunathan-Thangarajah, N., Bachoud-Levi, A. & Authier, F. (2015). Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis. PloS one, 10(6), e0128353. doi:10.1371/journal.pone.0128353

Vandendriessche, C., Bastian, M., Peyre, H., Stordeur, C., Asquaviva, E., Bahadori, S., Delorme, R. & Sackur, J. (2017). Attentional Lapses in Attention-Deficit/Hyperactivity Disorder: Blank Rather Than Wandering Thoughts. Psychological Science, 28(10), 1375-1386. doi:10.1177/0956797617708234

Varani, K., Bachoud-Levi, A., Mariotti, C., Tarditi, A., Abbracchio, M., Gasperi, V., Borea, P., Dolbeau, G., Gellera, C., Solari, A., Rosser, A., Naji, J., Handley, O., Maccarrone, M., Peschanski, M., Didonato, S. & Cattaneo, E. (2007). Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Neurobiology of Disease, 27(1), 36-43. doi:10.1016/j.nbd.2007.03.011

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & CYST-HD Study Group, . (2017). A randomized, Double-Blind, placebo-controlled trial evaluating cystéamine in Huntington’s disease. Mov. Disord., 32(6), 932-936

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & Cyst-Hd Study, G. (2017). A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 32(6), 932-936. doi:10.1002/mds.27010